Back to search

Article

FGF23 is a potential prognostic biomarker in uterine sarcoma

2023-08-23

Abstract excerpt

<h4>Background</h4> Uterine sarcoma (US) is a highly malignant cancer with poor prognosis and high mortality in women. In this study, we evaluated the expression of human fibroblast growth factor 23 (FGF23) in different US subtypes and the relationship between survival and clinicopathological characteristics. <h4>Methods</h4> We conducted a comparative analysis of FGF23 gene expression in different pathological ty...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bdcdbc22-c2c6-5456-93ce-32de32583d42
DOI
10.1101/2023.08.20.23294198
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FGF23 is a potential prognostic biomarker in uterine sarcomaDOI 10.1101/2023.08.20.23294198
Select a neighboring publication to make it the new centre.